透過您的圖書館登入
IP:18.223.28.70
  • 期刊

The Effect of β-adrenergic Receptor Blocker on Long-term Survival Rate in Patients with Heart Failure and Myocardial Infarction (Non-direct Association with Myocardial Infarction): A Systematic Review and Meta-analysis

摘要


Objective To make a systematic review of blood pressure control and outcome in patients with myocardial infarction and heart failure. Methods Up to March 2021, we searched the published research reports of emergency department, ICU, EICU and ward of adults (over 18 years old). We included case-control, cohort, cross-sectional and observational studies to report the changes of physiological indicators and outcomes of patients with different treatment methods. Findings Of 1550 articles scanned, we included 15 studies from 8 countries and areas in the meta-analysis. The pooled studies included 153439 samples. β-adrenergic receptor blockers have a positive effect on the survival rate of patients with heart failure and myocarpal infection (non-direct association with myocarpal infection). In particularly, treatment with ACEI combined (OR = 0.68 [0.65, 0.70]). The use of β-adrenergic blockers, which effectively produces a protective effect, is a favorable factor. It was concluded that β-adrenergic blockers are recommended in patients with heart failure and myocardial infarction (not directly related to myocardial infarction) unless there are contraindications or serious adverse effects to either β-adrenergic blocker.

參考文獻


Gheorghiade M, Bonow RO. Chronic heart failure in the United States: a manifestation of coronary artery disease. Circulation. 1998; 97:282-9.
Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009 07 21;339 jul21 1:b2535. doi: http://dx. doi. org/10.1136/bmj. b2535 PMID: 19622551.
Konishi H, Miyauchi K, Kasai T, Tsuboi S, Ogita M, Naito R, Nishizaki Y, Okai I, Tamura H, Okazaki S, Isoda K, Daida H. Long-term effect of beta-blocker in ST-segment elevation myocardial infarction in patients with preserved left ventricular systolic function: a propensity analysis. Heart Vessels 2016;31: 441–448.
Lee YH, Park JS, Tahk SJ, Hwang GS, Yoon MH, Choi SY, Choi BJ, Lim HS, Yang HM, Seo KW, Shin JH. b-Blocker therapy in the era of primary percutaneous intervention for ST elevation myocardial infarction. Cardiology 2015;132:91–100.
Yang JH, Hahn JY, Song YB, Choi SH, Choi JH, Lee SH, Kim JH, Ahn YK, Jeong MH, Choi DJ, Park JS, Kim YJ, Park HS, Han KR, Rha SW, Gwon HC. Association of b-blocker therapy at discharge with clinical outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. JACC Cardiovasc Interv 2014;7:592–601.

延伸閱讀